Barings BDC, Inc. (BBDC) stock: key figures, P/E, revenue and dividend
Financials · United States · ISIN US06759L1035
Barings BDC, Inc. financials
| Fiscal year | 2025 |
|---|---|
| EBIT | 101.92 m USD |
| Net income | 101.92 m USD |
| Diluted EPS – continuing operations | 1.12 USD |
Full history since 2003, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Barings BDC, Inc.
Barings BDC, Inc. is a publicly traded Real Estate, externally managed investment company that has elected to be treated as a business development company under the Investment Company Act of 1940. It seeks to invest primarily in senior secured loans, first lien debt, unitranche, second lien debt, subordinated debt, equity co-investments and senior secured private debt investments in private middle-market companies that operate across a wide range of industries. It specializes in mezzanine, leveraged buyouts, management buyouts, ESOPs, change of control transactions, acquisition financings, growth financing, and recapitalizations in lower middle market, mature, and later stage companies. It invests in manufacturing and distribution; business services and technology; transportation and logistics; consumer product and services. It invests in United States. It invests in companies with EBITDA of $10 million to $75 million, typically in private equity sponsor backed. The firm prefers to invest in companies having maximum revenue of $200 million and having EBITDA value between $10 million and $75 million.
More stocks
- FrankSpeech Network, Inc. (MLMC)
- FIRST FINANCIAL CORP /IN/ (THFF)
- Horng Terng Automation Co., Ltd. (7751.TWO)
- FARMERS NATIONAL BANC CORP /OH/ (FMNB)
- Jiangxi Guoguang Commercial Chains Co Ltd (605188.SS)
- Altamir SCA (LTA.PA)
- Odyssey Therapeutics, Inc. Common Stock (ODTX)
- Genuit Group PLC (GEN.L)
- Hunan Er Kang Pharmaceutical (300267.SZ)
- Bloomin' Brands, Inc. (BLMN)
- KELLY SERVICES INC (KELYB)
- Whirlpool China Co Ltd (600983.SS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.